These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24053487)

  • 1. Nod-like receptors in head and neck squamous cell carcinoma.
    Millrud CR; Kvarnhammar AM; Tajti J; Munck-Wikland E; Uddman R; Cardell LO
    Acta Otolaryngol; 2013 Dec; 133(12):1333-44. PubMed ID: 24053487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Junctional Adhesion Molecule-A in Head and Neck Squamous Cell Carcinoma.
    Kurose M; Kakuki T; Takano K; Kondo A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Kohno T; Kojima T; Himi T
    Adv Otorhinolaryngol; 2016; 77():92-7. PubMed ID: 27115511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide-binding oligomerization domain 2 (NOD2) activation induces apoptosis of human oral squamous cell carcinoma cells.
    Yoon HE; Ahn MY; Kwon SM; Kim DJ; Lee J; Yoon JH
    J Oral Pathol Med; 2016 Apr; 45(4):262-7. PubMed ID: 26332444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
    Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
    Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma.
    Sanada T; Islam A; Kaminota T; Kirino Y; Tanimoto R; Yoshimitsu H; Yano H; Mizuno Y; Okada M; Mitani S; Ugumori T; Tanaka J; Hato N
    Laryngoscope; 2020 May; 130(5):E327-E334. PubMed ID: 31219623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ICAM-5 (telencephalin) gene expression in head and neck squamous carcinoma tumorigenesis and perineural invasion!
    Maruya SI; Myers JN; Weber RS; Rosenthal DI; Lotan R; El-Naggar AK
    Oral Oncol; 2005 Jul; 41(6):580-8. PubMed ID: 15975520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo.
    Gutschalk CM; Herold-Mende CC; Fusenig NE; Mueller MM
    Cancer Res; 2006 Aug; 66(16):8026-36. PubMed ID: 16912178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of tumor marker expression with nodal disease burden in metastatic head and neck cancer.
    Trivedi S; Mattos J; Gooding W; Godfrey TE; Ferris RL
    Otolaryngol Head Neck Surg; 2013 Aug; 149(2):261-8. PubMed ID: 23625795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-8 promotes HNSCC progression on CXCR1/2-meidated NOD1/RIP2 signaling pathway.
    Chan LP; Wang LF; Chiang FY; Lee KW; Kuo PL; Liang CH
    Oncotarget; 2016 Sep; 7(38):61820-61831. PubMed ID: 27557518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 3 signaling induces apoptosis in human head and neck cancer via survivin associated pathway.
    Nomi N; Kodama S; Suzuki M
    Oncol Rep; 2010 Jul; 24(1):225-31. PubMed ID: 20514466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 directly influences proliferation and invasion potential of head and neck cancer cells.
    Kanazawa T; Nishino H; Hasegawa M; Ohta Y; Iino Y; Ichimura K; Noda Y
    Eur Arch Otorhinolaryngol; 2007 Jul; 264(7):815-21. PubMed ID: 17310346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
    Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
    BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
    Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
    Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine-induced anticancer activities in FaDu head and neck squamous cell carcinoma cells.
    Seo YS; Yim MJ; Kim BH; Kang KR; Lee SY; Oh JS; You JS; Kim SG; Yu SJ; Lee GJ; Kim DK; Kim CS; Kim JS; Kim JS
    Oncol Rep; 2015 Dec; 34(6):3025-34. PubMed ID: 26503508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
    Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
    Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
    Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.